					<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-14.2.1'-->
<!--Jetpack_Sitemap_Buffer_News-->
<?xml-stylesheet type="text/xsl" href="//bioutah.org/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://bioutah.org/cancervax-develops-novel-smart-mrna-to-harness-pre-existing-immunity-in-99-of-world-population/</loc><lastmod>2026-07-16T20:39:23Z</lastmod><news:news><news:publication><news:name>BioUtah</news:name><news:language>en</news:language></news:publication><news:title>CancerVax Develops Novel Smart mRNA to Harness Pre-Existing Immunity in 99% of World Population</news:title><news:publication_date>2026-07-16T20:39:23Z</news:publication_date><news:genres>Blog</news:genres></news:news></url><url><loc>https://bioutah.org/halia-therapeutics-presents-two-aaic-2026-posters-on-ht-4253-for-alzheimers-prevention-in-apoe4-carriers/</loc><lastmod>2026-07-16T16:58:46Z</lastmod><news:news><news:publication><news:name>BioUtah</news:name><news:language>en</news:language></news:publication><news:title>Halia Therapeutics Presents Two AAIC 2026 Posters on HT-4253 for Alzheimer&amp;#039;s Prevention in APOE4 Carriers</news:title><news:publication_date>2026-07-16T16:58:46Z</news:publication_date><news:genres>Blog</news:genres></news:news></url><url><loc>https://bioutah.org/sintx-secures-3-2m-advanced-ceramic-component-orders/</loc><lastmod>2026-07-16T16:54:27Z</lastmod><news:news><news:publication><news:name>BioUtah</news:name><news:language>en</news:language></news:publication><news:title>SINTX Secures $3.2M Advanced Ceramic Component Orders</news:title><news:publication_date>2026-07-16T16:54:27Z</news:publication_date><news:genres>Blog</news:genres></news:news></url><url><loc>https://bioutah.org/renew-labs-receives-accreditation-from-the-college-of-american-pathologists/</loc><lastmod>2026-07-16T16:50:44Z</lastmod><news:news><news:publication><news:name>BioUtah</news:name><news:language>en</news:language></news:publication><news:title>Renew Labs Receives Accreditation from the College of American Pathologists</news:title><news:publication_date>2026-07-16T16:50:44Z</news:publication_date><news:genres>Blog</news:genres></news:news></url><url><loc>https://bioutah.org/renew-biotechnologies-unifies-wasatch-biolabs-and-resonant-under-one-brand-to-advance-sequencing-based-diagnostics/</loc><lastmod>2026-07-16T16:51:28Z</lastmod><news:news><news:publication><news:name>BioUtah</news:name><news:language>en</news:language></news:publication><news:title>Renew Biotechnologies Unifies Wasatch BioLabs and Resonant Under One Brand to Advance Sequencing-Based Diagnostics</news:title><news:publication_date>2026-07-16T16:48:21Z</news:publication_date><news:genres>Blog</news:genres></news:news></url><url><loc>https://bioutah.org/u-of-u-startup-advances-mri-accessibility-amid-new-federal-requirements/</loc><lastmod>2026-07-16T16:47:16Z</lastmod><news:news><news:publication><news:name>BioUtah</news:name><news:language>en</news:language></news:publication><news:title>U of U Startup Advances MRI Accessibility Amid New Federal Requirements</news:title><news:publication_date>2026-07-16T16:47:16Z</news:publication_date><news:genres>Blog</news:genres></news:news></url><url><loc>https://bioutah.org/merit-medical-ribbon-cutting-facility-tour/</loc><lastmod>2026-07-16T20:19:55Z</lastmod><news:news><news:publication><news:name>BioUtah</news:name><news:language>en</news:language></news:publication><news:title>Merit Medical Ribbon Cutting &amp;amp; Facility Tour</news:title><news:publication_date>2026-07-16T16:44:49Z</news:publication_date><news:genres>Blog</news:genres></news:news></url><url><loc>https://bioutah.org/gpx-embolic-device-meets-primary-endpoints-in-ide-pivotal-trial/</loc><lastmod>2026-07-14T19:17:43Z</lastmod><news:news><news:publication><news:name>BioUtah</news:name><news:language>en</news:language></news:publication><news:title>GPX® Embolic Device meets Primary Endpoints in IDE Pivotal Trial</news:title><news:publication_date>2026-07-14T19:17:43Z</news:publication_date><news:genres>Blog</news:genres></news:news></url></urlset>
